A phase 1, open-label, randomized, single-dose, three-treatment, three period, six-sequence crossover study to evaluate the effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, a single tablet regimen in healthy volunteers.

Trial Profile

A phase 1, open-label, randomized, single-dose, three-treatment, three period, six-sequence crossover study to evaluate the effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, a single tablet regimen in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Dec 2015

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top